Stocker A, Trojan A, Elfgen C, Hilbers ML, et al. Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer. Breast Cancer Res Treat 2020 Jul 7. pii: 10.1007/s10549-020-05772.
PMID: 32638236